Earlier on November 25, Evercore ISI initiated coverage of DexCom with an In Line rating and $68 price target. While ...

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to Overweight from Equal Weight with a price target of $75, which was up from ...

Apple users had a banner year when it came to new smart home devices. Of all the ones I tested, here are my favorite Apple ...

Neither had a great year in 2025, but the future is looking bright.

Samsung plans to showcase a Brain Health feature at CES 2026 that uses wearable and smartphone data to flag early dementia ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

Hisense will debut the S6 FollowMe at CES 2026, a 32-inch 4K mobile display with a 10-hour battery and wheeled stand for ...

DexCom (DXCM) announced the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults with Type 2 diabetes on glargine U-100 long-acting ...

Exclusive: Memories.ai's wearable pin is now more lightweight and records for longer. But there's a bigger story to tell here.

Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy ...

DexCom, which has underperformed its medical equipment and S&P 500 peers in a big way in 2025, could be staring at better prospects next year. Stelo is facing vast and underpenetrated prediabetes and ...

Smart home AI is reshaping the way we interact with our living spaces, integrating predictive automation across appliances, lighting, and security systems. IoT predictions suggest 75 billion connected ...